GLP-1 Drugs for Women Over 40 - Why Midlife Weight Gain Is Different

from GLP-1 Drugs for Women Over 40 · host Inception Point AI

Julia Cartwright explores why GLP-1 drugs like semaglutide and tirzepatide achieve 20-23% weight loss in menopausal women despite hormonal chaos. Drawing on SURMOUNT trial data involving over 2,500 women, she examines how estrogen decline drives visceral fat and insulin resistance—and why these medications work across all reproductive stages, challenging assumptions about midlife metabolism. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.

Episode metadata supplied by the publisher feed · Published Apr 7, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

GLP-1 Drugs for Women Over 40 - Why Midlife Weight Gain Is Different

0:00 23:19

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GLP-1 Drugs for Women Over 40?

This episode is 23 minutes long.

When was this GLP-1 Drugs for Women Over 40 episode published?

This episode was published on April 7, 2026.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this GLP-1 Drugs for Women Over 40 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!